|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1301 PENNSYLVANIA AVENUE, N.W., SUITE 400 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20004-1701 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 17831-12
|
||||||||
|
6. House ID# 310010000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Greg Crist |
Date | 10/20/2022 12:11:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to payment reform, ACOs and bundling
Issues related to Protecting Access to Medicare Act
Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act
Issues related to Medicare coverage reform
Issues related to coverage of telehealth services
Issues related to Medicare coverage for digital health technologies
Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Greg |
Crist |
|
|
|
Amanda |
Walsh |
|
|
|
Sarah |
Killeen |
|
|
|
Kim |
Zimmerman |
|
|
|
Nick |
Halsted |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act
Issues related to the medical supply chain
Issues related to implementation of the 21st Century Cures Act
Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies
Issues related to third party servicing of medical devices
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
Issues related to coverage and reimbursement of COVID-19 diagnostic tests
Issues related to the Valid Act of 2021 - HR 4128/S. 2209
Improving Medical Device Servicing to Protect Patient Safety Act
Issues related to the Critical Medical Infrastructure Right-to-Repair Act
Issues related to Health Equity
Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932
Issues related to HR 1319/S 2401 Rescue America Plan
Issues related to COVID-19 Clinical Testing & Testing Supplies
Issues related to Public Health Emergency Preparedness
Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act
COVID-19 Clinical Testing and Testing Supplies
Issues related to consumer and health data privacy
Issues related to MDUFA Reauthorization
Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act
Issues related to HR 7667, Food and Drug Amendments of 2022
Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act
Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.
Issues related to S. 3799, PREVENT Pandemics Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), White House Office, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Greg |
Crist |
|
|
|
Sarah |
Killeen |
|
|
|
Amanda |
Walsh |
|
|
|
Kim |
Zimmerman |
|
|
|
Nick |
Halsted |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to appropriations and user fee funding for the Food and Drug Administration
Appropriations - Labor, Health and Human Services, Education, and Related Agencies
Issues related to IGNITE America Innovation Act
Issues related to HR 1319/S 2401 Rescue America Plan
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sarah |
Killeen |
|
|
|
Greg |
Crist |
|
|
|
Amanda |
Walsh |
|
|
|
Kim |
Zimmerman |
|
|
|
Nick |
Halsted |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Issues related to Corporate Tax Policy
Issues related to IGNITE America Innovation Act
Section 1202 - Qualified Small Business Stock
Issues related to R&D Tax Credit
Issues related to Section 1202 - Qualified Small Business Stock
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sarah |
Killeen |
|
|
|
Greg |
Crist |
|
|
|
Amanda |
Walsh |
|
|
|
Kim |
Zimmerman |
|
|
|
Nick |
Halsted |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Issues related to the Phase I Trade Agreement with China
Issues related to the Free Trade Agreement with Brazil
Issues related to the Free Trade Agreement with Kenya
Issues related to US MADE and domestic supply chain resilience
Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU
Issues related to Free Agreement with Ecuador
Issues related to TRIPS Waiver for COVID-19 diagnostic & treatment products
Issues related to USICA/Competes
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), State - Dept of (DOS), Commerce - Dept of (DOC), Natl Security Council (NSC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Walsh |
|
|
|
Greg |
Crist |
|
|
|
Sarah |
Killeen |
|
|
|
Kim |
Zimmerman |
|
|
|
Nick |
Halsted |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amanda |
Walsh |
|
|
|
Greg |
Crist |
|
|
|
Sarah |
Killeen |
|
|
|
Kim |
Zimmerman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |